Dialysis Market (By Type: Product, Services, By Dialysis Type: Hemodialysis (HD), Peritoneal dialysis (PD); By End User: Dialysis Center and Hospitals, Home Care) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030
The global Dialysis market size was estimated at USD 108.7 billion in 2021 and is expected to surpass around USD 196.1 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 6.78% during the forecast period 2022 to 2030.
- In 2021, services segment accounted largest market share 78.6%
- In 2021, product segment has contributed largest share 21.4%
- In 2021, hemodialysis dialysis segment has registered 56% market share
- North America has garnered highest revenue share 40.5% in 2021
- Asia Pacific region is expected to grow at a CAGR of 5.8% from 2022 to 2030
Dialysis is a technique used to remove waste products, such as urea and creatinine from the blood due to abnormal functioning of the kidneys and is usually required for people suffering from chronic renal failure. The procedure is important during the treatment of end-stage renal disease (ESRD) and kidney transplant. In this procedure, the blood is purified, excess fluid and toxins are removed, and electrolyte balance is restored. Dialysis is carried out in two ways, namely, hemodialysis and peritoneal dialysis. In hemodialysis, waste products such as urea are removed extracorporeally from the blood of the patient. In peritoneal dialysis, the peritoneum in the abdomen is used for dialysis.
The market growth is attributed to the increase in number of diabetic and hypertension patients, surge in funding for the development of new products, and a rise in the number of end stage renal disease (ESRD) patients. Furthermore, dialysis is a preferred technique over kidney transplantation, which is expected to further boost the dialysis market growth. Moreover, the rise in geriatric population, increase in healthcare expenditure, and growth in disposable income are expected to fuel the market growth. However, lack of awareness about kidney diseases, product recall, and reduction in reimbursements for dialysis are expected to hinder the market growth.
The dialysis market is segmented on the basis of type, Product & Service, end user, and region. On the basis of type, it is bifurcated into hemodialysis and peritoneal dialysis. Hemodialysis is categorized into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is further classified into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). On the basis of Product & Service, it is divided into equipment, consumables, drugs, and services. Equipment is further categorized into dialysis machines, water treatment systems, and others. Consumables are classified into dialyzers, catheters, and transfer sets. On the basis of end users, it is bifurcated into in-center dialysis and home dialysis. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Report Scope of the Dialysis Market
Market Size in 2022
USD 116.07 Billion
Market Size by 2030
USD 196.1 Billion
Growth Rate from 2022 to 2030
CAGR of 6.78%
2022 to 2030
Type, Dialysis Type, End User, Geography
Fresenius Se and Co. Kgaa, Asahi Kasei Corporation, B. Braun Melsungen Ag, Baxter International Inc., Becton, Dickinson And Company (C. R. Bard, Inc.), Davita, Angiodynamics Inc., Diaverum Deutschland Gmbh., Nikkiso Co. Ltd., Nipro Corporation, Medtronic, Asahi Kasei Corporation
Dialysis Type Insights
Dialysis Market is divided into two categories i.e Hemodialysis and Peritoneal Dialysis’s. Hemodialysis is further classified into two types: conventional and everyday (short daily and nocturnal hemodialysis). Hemodialysis produced the most revenue of the two in 2021 and is predicted to continue to dominate revenue throughout the projection period. Waste materials like as urea are removed extracorporeally from the inmate's blood during haemodialysis. The peritoneum in the stomach is used in dialysis in peritoneal dialysis. During the foreseeable years, haemodialysis is likely to stay dominant. Inadequate peritoneal treatment training in both developed and developing nations has reduced peritoneal treatment preference. Aside from the therapeutic benefits linked with this treatment, such as the reduced time required to operate and adopt arteriovenous fistula (AV Fistula), the demand for haemodialysis is increasing.
The market is divided into two types: Services and Products. In 2021, services made up the greatest portion, mostly due to the expansion of renal care centres with modern equipment for both chronic and urgent treatment throughout the world, as well as a growing emphasis on quality-care delivery to patients by service providers. Additionally, increasingly patient-focused and profit-driven business models among care providers are raising service demand. The product sector is predicted to develop steadily in the coming years as the number of local and regional companies in this market increases to meet the increased demand for innovative goods and consumables.
End consumers in the worldwide market are classified as centres and hospitals, as well as home care. In terms of value, dialysis treatment centres accounted for the largest market share in 2021, owing to favourable reimbursement offered by renal facilities and hospitals for renal treatments, an expanding patient population with CKD and ESRD, and increasing population healthcare spending. Homecare, on the other hand, is expected to be the fastest-growing category over the projected period, with a significantly higher CAGR. The hospital segment is expected to develop in the near future because to an increase in the number of COVID-19.
In 2021, the North American market was worth USD 39.87 billion. During the projection period, North America is expected to dominate the market share. The high incidence of CKD and ESRD in the United States and Canada, together with greater treatment rates in these countries, are expected to drive market growth over the projected period. The United States is also expected to see an increase in demand for services and products as a result of the rising prevalence of coronavirus infections and associated renal failures. Europe is predicted to be the second biggest region in this market in terms of size, with moderate long-term growth. The region's rapid expansion is mostly owing to a rising senior population suffering from renal problems.
Furthermore, Asia-Pacific is predicted to see comparatively large value development in this market. Funding from public players to enhance access to renal care is expected to boost market growth throughout the projected period. The National Health and Family Planning Commission of China established regulations for the fundamental standard and administration of haemodialysis facilities in December 2016, with the goal of standardising the growth of autonomous such centres across the nation. Such a well-established regulatory framework for renal treatment facilities is expected to drive market growth in Asia Pacific throughout the forecast period.
In Brazil, the increased prevalence of CKD among the senior population is fueling the expansion of the market for services and goods. Due to the delayed diagnosis of chronic CKD and ESRD, the Middle East and Africa region is anticipated to develop slowly to moderately over the forecast period. Though, increased urbanisation in the area and rising awareness regarding the seriousness of renal illnesses are expected to drive revenue in this region throughout the projection period.
Some of the prominent players in the Dialysis Market include:
- Fresenius Se and Co. Kgaa
- Asahi Kasei Corporation
- B. Braun Melsungen Ag
- Baxter International Inc.
- Becton, Dickinson And Company (C. R. Bard, Inc.)
- Angiodynamics Inc.
- Diaverum Deutschland Gmbh.
- Nikkiso Co. Ltd.
- Nipro Corporation
- Asahi Kasei Corporation
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Dialysis market
- Dialysis Machines
- Water Treatment Systems
- Others dialysis equipment
- Other dialysis consumables
- Dialysis Drugs
By Dialysis Type
- Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
- Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)
By End User
- Dialysis Center and Hospitals
- Home Care
- United Kingdom
- Rest of Europe
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of Middle East & Africa
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Dialysis industry analysis from 2022 to 2030 to identify the prevailing Dialysis industry opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the global Dialysis industry segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global Dialysis industry trends, key players, market segments, application areas, and market growth strategies.